CSTL · Castle Biosciences Inc
United States · RS rating 78 · As of 2026-11-03
| Price | 35.14 USD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 78 / 46 / 87 / 79 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 28 / 43 / 13 |
| Industry group (rank) | Medical-Services (63) |
| EPS growth Q/Q | -512.5% |
| Sales growth Q/Q | +4.8% |
| Distance from 52-week high | +18.4% |
| Market cap (USD) | $717.7M |